farletuzumab humanized monoclonal investigated treatment ovarian drug developed morphotek inc targeted folate receptor alpha frÎ± overexpressed cancers epithelial ovarian cancer eoc nonsmallcell lung farletuzumab uses following mechanisms common adverse effects include hypersensitivity reactions fever chills headache fatigue monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikifarletuzumab